Cargando…
Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?
Background: Patients with COVID-19 have an increased risk of thromboembolic disease, this has been partly attributed to an excessive inflammatory response that is associated with hypercoagulability; patients develop thrombotic complications with rates of 6.4% in non-critically ill and 15 to 31 % in...
Autores principales: | Marquez, Félix Gibrant, Riviello-Goya, Santiago, Vargas Ruiz, Angel Gabriel, Ortíz Brizuela, Edgar, Gil López, Fernando, Gutierrez Marín, Alfredo, Gonzalez Lara, María Fernanda, Ponce de Léon Garduño, Alfredo, Sifuentes Osornio, José, Rangel-Patiño, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330371/ http://dx.doi.org/10.1182/blood-2020-136240 |
Ejemplares similares
-
Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020) -
Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020) -
COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic
por: Almukhtar, Talat, et al.
Publicado: (2020) -
Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
por: Madeeva, Daria V, et al.
Publicado: (2021) -
Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination
por: Ge, Melissa, et al.
Publicado: (2021)